• VIDEO: Avicenna Alliance
    at the European Parliament

    At the invitation of the European Parliament, Avicenna Alliance's leaders supported by senior people from FDA, ANSYS, Medtronic, CIPLA, VPHi, EFGCP and RPP, have explained to delegations from Europe, USA, India and Japan the central role played by in silico healthcare to accelerate medical innovation.

    View the video!

Avicenna Alliance news

The Commission launched a new call for advanced health approaches to rapidly respond to COVID-19

On 19 May the European Commission launched a new call for an Expression of Interest with a budget of...

find out more ›

Members of the European Parliament call for supporting health policies and health systems in the next Multiannual Financial Framework

On 1 May Members of the European Parliament (MEPs) sent a letter...

find out more ›

Launch of the European COVID-19 Data Platform

On 20 April the Commission together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and...

find out more ›

Show all activites

Avicenna Alliance the Association for Predictive Medicine

The Avicenna Alliance, is an association of industry and renowned academia/healthcare organizations who have a commercial or research interest in the development of in silico medicine. The Association, established in 2015, has its origins in the Virtual Physiological Human Initiative, a European Commission endorsed research area on computer modeling and simulation. Tasked by the European Commission with developing a “Roadmap for in silico medicine”, the Association now seeks to put this roadmap into policy and ensure the development of a regulated in silico market.

This Association bridges the gap between the scientific community, industry and policy makers by advocating for policy changes that take into account scientific and market developments.

read more

Avicenna Alliance: 
enhanced knowledge, improved decisions, better outcomes

Sign up for our monthly newsletter!


Sign up